Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PET Positive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT01019278
What this trial is testing

Proton Beam Radiation Therapy and Cisplatin in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer and Positive Lymph Nodes

Who this might be right for
Cervical CancerStage IB Cervical CancerStage IIA Cervical Cancer+3 more
Abramson Cancer Center at Penn Medicine
Not applicableEnded earlyNCT01376856
What this trial is testing

Characteristics of Mediastinal Lymph Node With False Positive FDG PET/CT Results in Lung Cancer Staging : Relation With TB and Latent TB Infection

Who this might be right for
Lung Cancer
Yonsei University 33
Not applicableStudy completedNCT01081600
What this trial is testing

89Zr-trastuzumab PET for Imaging the Effect of HSP90 Inhibition

Who this might be right for
Breast Cancer
University Medical Center Groningen 7
Testing effectiveness (Phase 2)Looking for participantsNCT06260033
What this trial is testing

Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor-Positive Breast CarcinomaMetastatic Breast Carcinoma
City of Hope Medical Center 18
Not applicableLooking for participantsNCT07087080
What this trial is testing

Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules

Who this might be right for
Solitary Pulmonary NodulesLung Cancer
Hasselt University 350
Large-scale testing (Phase 3)Study completedNCT03673943
What this trial is testing

Imaging of Patients With Known or Suspected Somatostatin Receptor Positive Neuroendocrine Tumors Using Cu64-DOTATATE

Who this might be right for
Neuroendocrine Tumors
Radiomedix, Inc. 63
Testing effectiveness (Phase 2)Study completedNCT01869725
What this trial is testing

Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT

Who this might be right for
Adult MedulloblastomaChildhood MedulloblastomaNeuroblastoma+2 more
Sue O'Dorisio 68
Not applicableLooking for participantsNCT07557225
What this trial is testing

18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Urothelial Carcinoma (UC)Colorectal Cancer+11 more
Peking University First Hospital 200
Early research (Phase 1)Study completedNCT06129422
What this trial is testing

Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Nihon Medi-Physics Co., Ltd. 10
Testing effectiveness (Phase 2)Looking for participantsNCT07593976
What this trial is testing

Evaluation of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT for Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in HER2 Positive Early Breast Cancer

Who this might be right for
Breast Cancer
Centre Henri Becquerel 42
Not applicableUnknownNCT03935672
What this trial is testing

PEARL PET-based Adaptive Radiotherapy Clinical Trial

Who this might be right for
Oropharyngeal Cancer
Velindre NHS Trust 50
Very early researchEnded earlyNCT04727632
What this trial is testing

[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial

Who this might be right for
Estrogen Receptor Positive Breast Cancer
University of Utah 2
Not applicableUnknownNCT05982626
What this trial is testing

Study of 68Ga /131I SGMIB-ZT-199 PET Imaging Targeting HER2-positive in the Diagnosis of Metastatic Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Huashan Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT04235114
What this trial is testing

Evaluation of 89Zr-DFO-nimotuzumab for Non-invasive Imaging of EGFR+ Cancers by Positron Emission Tomography (PET)

Who this might be right for
Lung CancerColorectal Cancer
University of Saskatchewan 14
Testing effectiveness (Phase 2)Ended earlyNCT02409316
What this trial is testing

[18F]FES PET/CT in Endocrine Refractory Breast Cancer

Who this might be right for
Estrogen Receptor Positive Breast CancerBreast NeoplasmMetastatic Breast Cancer
University of Pennsylvania 6
Early research (Phase 1)Study completedNCT03242993
What this trial is testing

[18F]-AZAFOL AS POSITRON EMISSION TOMOGRAPHY (PET) TRACER in FR Positive Cancer Imaging

Who this might be right for
Metastatic Cancer LungMetastatic Ovarian Cancer
University of Lausanne Hospitals 15
Not applicableActive Not RecruitingNCT05622721
What this trial is testing

REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs

Who this might be right for
DysbiosisClostridium DifficilePet-Human Bonding+1 more
University of Pennsylvania 200
Not applicableEnded earlyNCT03619044
What this trial is testing

The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane.

Who this might be right for
HER2-positive Breast Cancer
Institut Claudius Regaud 4
Not applicableEnded earlyNCT05068726
What this trial is testing

Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients

Who this might be right for
Metastatic Breast Cancer
GE Healthcare 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07527806
What this trial is testing

Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging

Who this might be right for
Breast Cancer
Peking University Cancer Hospital & Institute 156
Next Page